Shenzhen Chipscreen Biosciences Co Net debt/EBITDA
What is the Net debt/EBITDA of Shenzhen Chipscreen Biosciences Co?
The Net debt/EBITDA of Shenzhen Chipscreen Biosciences Co., Ltd. is 5,565.30
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with net debt/ebitda similar to Shenzhen Chipscreen Biosciences Co
- Mechel PJSC has Net debt/EBITDA of 3,412.93
- MAN SE has Net debt/EBITDA of 3,439.00
- Cresud has Net debt/EBITDA of 3,527.59
- Dealnet Capital has Net debt/EBITDA of 3,642.37
- EPI () has Net debt/EBITDA of 4,336.87
- KT has Net debt/EBITDA of 4,758.28
- Shenzhen Chipscreen Biosciences Co has Net debt/EBITDA of 5,565.30
- Aemetis Inc has Net debt/EBITDA of 6,195.62
- TTL Beteiligungs- und Grundbesitz-AG has Net debt/EBITDA of 6,283.54
- Prospect Resources has Net debt/EBITDA of 6,818.24
- Enel Chile S.A has Net debt/EBITDA of 7,379.66
- Boeing Co has Net debt/EBITDA of 7,664.71
- SK Telecom Co Ltd has Net debt/EBITDA of 7,844.35